Adamant Biomedical Investments AG

13F Portfolio Filings

Latest 13F report
Q4 2014 - Feb 13, 2015
Value $
$418M
Signature - Title
Dr. Cyrill Zimmerman - CEO
Location
Freischuetzgasse 3, Zurich, Switzerland
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2014 101 $418M +$52.4M -$73.5M -$21.1M CELG, BIIB, GILD, AMGN, B108PS 13F-HR 2/13/2015, 04:29 PM
Q3 2014 96 $391M $0 $0 GILD, CELG, BIIB, AMGN, B108PS 13F-HR 11/14/2014, 03:18 PM
Q2 2014 0 13F-NT 8/7/2014, 10:04 AM
Q1 2014 0 13F-NT 4/29/2014, 11:31 AM
Q4 2013 0 13F-NT 2/3/2014, 03:46 PM